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Introduction
Chymase is a chymotrypsin-like proteinase released from activated mast cells along with other pre-formed, granule-associated mediators such as histamine, heparin, and tryptase (1-3). The tissue distribution, structure, and catalytic features of mammalian mast cell chymases have been examined extensively in the past decade (for review see 4). In rodents, virtually all mast cells package one or more types of chymase into their secretory granules (5). In humans, however, only a subset of mast cells contain immunoreactive chymase (6) . The proportion of human chymase-positive mast cells varies strikingly with tissue location. In the dermal layers of the skin, for example, 99% of mast cells contain immunoreactive chymase, whereas in the alveoli of the lung only 7% of mast cells contain chymase (6.7).
In airway tissues, the concentration of chymase-containing mast cells in specific tissue microenvironments assumes obvious importance in light of the variety of extracellular roles proposed recently Supported by the Cystic Fibrosis Foundation. EKT was supported by the American Lung Association of California Research Fund and is a recipient of an Edward Livinston Trudeau Award. GHC is an RJR Nabisco Research Scholar in Pulmonary.
' Correspondence to: Dr. George H. Caughey, Cardiovascular Research Inst., University of California, San Francisco, CA 94143-091 1. 130 cells/mm3), whereas in smooth muscle the concentration of chymase-positive mast cells (450 & 200 cells/mm3) was only 14 * 4% that of total mast cells (2920 * 620 cells/mm3). Of all chymase-containing mast cells in the airway subepithelium, 30 2 4% were located within 20 pm of submucosal glands. Although the percentage of chymasecontaining cells varied, the absolute concentration of chymase-containing mast cells was similar in all compartments. These results reveal a differential distribution of mast cell subpopulations in human airway and suggest that mast cells containing chymase are near gland and smooth muscle targets. (J Histochem Cytochem 40:781-786, 1992) KEY WORDS: Airway submucosal glands; Airway smooth muscle; Enzyme histochemistry; Pulmonary hypertension. for chymase. Chymase is capable of hydrolytically inactivating bronchoactive peptides such as bradykinin (8), substance P, and vasoactive intestinal peptide (9, 10) , and has potent angiotensin-converting enzyme activity (11) (12) (13) . In the skin, chymase appears to be an important determinant of the duration of calcitonin gene-related peptide (CGRP)-induced vasodilation after release from sensory nerves (14) . The enzyme could serve similar functions in the airway. Chymase strips components of glycocalyx from the surface of cultured airway epithelial cells (15) and is a highly potent secretagogue for cultured airway submucosal gland serous cells (16). In addition, chymase enhances histamine-induced cutaneous wheal formation in vivo (17) and can be hypothesized to exert similar effects on vascular permeability in other tissues, such as bronchi.
We undertook the present study to provide a quantitative morphological basis for evaluating the proposed physiological consequences of mast cell chymase release near cell targets in human bronchi.
Materials and Methods
Tissue Collection and Processing. Samples of human bronchi were obtained under protocols approved by the Medical Committee for the Use of Human Subjects in Research (Stanford University School of Medicine) and the Committee on Human Research (University of California, San Francisco). Bronchi from seven patients were obtained from lungs removed at the time of heart-lung transplantation. Six of these patients had primary pulmonary hypertension and one patient had pulmonary hypertension secondary to a ventricular septal defect. Tissues were placed in ice-cold physiological saline solution immediately after surgical harvesting, then refrigerated at 4'C. Tissues were transferred to fixative within 12 hr in all instances.
Lung tissue from an additional patient was obtained after death from trauma sustained in a motor vehicle accident. All patients were non-smokers 15-35 years of age without known airway disease, interstitial fibrosis, or lung infections. The results of preoperative spirometric tests were available for four of the heart-lung transplant recipients and showed no significant airway obstruction. No patients were receiving medications (e.g., corticosteroids) known to alter the numbers of mast cells in tissues. Samples were trimmed of pulmonary parenchyma, fixed for 24 hr in Mota's lead acetate (1% lead acetate, 50% ethanol, 0.5% acetic acid, pH 4.9), dehydrated by immersion in graded solutions of ethanol (70%, 95%, loo%), embedded in glycol methacrylate, and cut into 2.5-pm sections onto glass slides. Fixation and embedding were performed at 4'C. To facilitate examination of general histological features, at least one section from each sample was stained with hematoxylin and eosin.
Metachromatic Staining. To identify all mast cells by staining the sulfated proteoglycans in secretory granules, bronchial sections were immersed in 0.05% methylene blue in H20 for 30 min. Slides were then rinsed in H20 and air-dried. Coverslips were applied using Cytoseal 60 (Stephens Scientific; Denville, NJ).
Enzyme Histochemistry. Sections adjacent to those selected for methylene blue staining were used for enzyme histochemistry. Cells containing chymotryptic activity were visualized using naphthol AS-D chloroacetate and Fast Blue BB (Sigma; St Louis, MO), as described by Benditt and Arase (18) and modified by Caughey et al. (19) . After incubation in histochemical reaction buffer at 37°C for 2-4 hr, slides were rinsed in H20 and counterstained with 0.05% basic fuchsin. Available data suggest that this enzyme histochemical procedure is specific for chymase in mast cells under the conditions used, which were refined initially using dog mastocytoma cells (19), which express a chymase that is remarkably similar to the human enzyme in both structural and catalytic properties (20) (21) (22) . Chymase and other chymotrypsin-like serine esterases hydrolyze naphthol AS-D chloroacetate (18,23,24) and related naphthol derivatives (25), generating the free naphthol AS-D, which forms an insoluble precipitate with the azo dye Fast Blue BB near the site of enzymatic hydrolysis. Mast cell staining is blocked by inhibitors or ester substrates of chymase (19,23), and the intensity of staining correlates positively with levels of extractable chymase activity (19). With prolonged incubations using this technique, light staining is also seen in neutrophils, presumably due to cathepsin G, a chymotrypsin-like enzyme similar to chymase. However, neutrophils are rea&ly distinguishable from mast cells on the basis of nuclear morphology, tissue location (if intravascular), and intensity of staining.
Counting of Mast Cells. In methylene blue-stained sections, extravascular cells containing metachromatic cytoplasmic granules were considered mast cells. In sections stained with naphthol AS-D-Fast Blue BB, extravascular cells containing intense blue cytoplasm or cytoplasmic granules were considered mast cells. All of the sections included the entire circumference of a bronchus. All mast cells in the region between the epithelial basement membrane and the cartilage were counted in each section. Mast cells thus identified were assigned to one of three compartments: (a) submucosal glands, (b) bronchial smooth muscle, and (c) "other" (meaning neither gland nor smooth muscle). All mast cells found within glands or airway smooth muscle, or within 20 pm of the perimeter of these structures, were assigned to the gland or smooth muscle compartment, respectively. For each bronchus, at least 100 methylene blue-staining mast cells in gland and smooth muscle Compartments combined were counted. This sometimes required counting two sections from a single specimen. A section adjacent to each of the methylene blue-stained sections was stained enzyme histochemically for chymase activity, and the stained cells were assigned to subepithelial compartments in a similar fashion.
For the purpose of converting the raw counts into an estimate of the numbers of mast cells in each section, the diameters of 100 mast cells for each type of stain were measured using a calibrated eyepiece (Model Kpl-W x 10; Carl Zeiss, Oberkochen, FRG). The mean mast cell diameter derived from these measurements was used to obtain an estimate of true mean diameter according to the following formula (26):
where D = the true mean mast cell diameter, d = the observed mean mast cell diameter, and t = the thickness of the tissue section. The true number of mast cell profiles was estimated by applying the following correction formula:
where n = the observed number of mast cell profiles and N = the true number of mast cells.
The areas of gland and smooth muscle compartments in each section were measured using a computerized image analyzer (TAS-plus; Leitz, Rockleigh, NJ) in the Laboratory for Cell Analysis at University of California, San Francisco. Individual tissue compartments imaged on a video monitor were outlined with a light pen and converted to estimates of area by the image analyzer. A camera lucida (SMZ-10; Nikon, Garden City, NY) then was used to draw scaled images of each whole tissue section. Areas of whole sections were measured using a computerized digitizer (Model lllA Digipad; GTCO, Columbia, MD). The area in which mast cells were counted was obtained by subtracting the areas contributed by the cartilage and lu- muscle or elsewhere in the subepithelium were significant w O . 0 5 ) . The chymase-containing mast cells were usually arrayed around the perimeter of submucosal gland acini (Figure 2b) and were almost never found within acini. The luminal diameter of the bronchi was 3.1 f 0.8 mm (mean 2 SE). In sections stained with hematoxylin and eosin, all bronchi had intact epithelium and were free of infiltration by inflammatory cells.
The concentration of total (i.e., methylene blue-positive) mast cells also varied among compartments in the sections from airways, being highest (2920 * 620 cells/mm3) near smooth muscle and lowest (910 * 130 cells/mm3) near glands (mean 2 SE) (see Figure 3) . The concentration of total mast cells near glands was significantly lower than the concentration near smooth muscle or elsewhere in the subepithelium (P<O.OOS and p<O.Ol, respectively). However, the concentration of chymase-positive mast cells was similar in all subepithelial compartments, i.e., 640 120 cells/mm3 near glands, 450 +. 200 cells/mm3 near smooth muscle, and 630 +. 150 cells/mm3 elsewhere in the subepithelium (mean f S E p>O.O5, all comparisons) (see Figure 3) . 
Results
The percentage of chymase-containing mast cells varied substantially among tissue compartments, being highest (73 2 9%) near glands and lowest (14 +. 4%) near smooth muscle (mean 2 SE) (see Figures 1 and 2) . The differences in the proportion of chymasepositive mast cells near glands as compared with those near smooth Glands?, airway smooth muscle ("Muscle") , and by the remainder of the subepithelium ("Other") were calculated as described in the text. Black bars show percentage of.total volume occupied in bronchi (mean f SE; n = 8 bronchi).
In the bronchial sections, 27 * 4% of the analyzed subepithelium was represented by gland tissue and 18 -c 2% by smooth muscle (Figure 4) . Therefore, although only 15 * 3% of all mast cells in the subepithelium were within 20 pm of glands, 30 4% of all chymase-containing mast cells were near glands (lible 1). Because of the low percentage of chymase-positive mast cells near smooth muscle and the relatively low percentage of the airway subepithelium represented by smooth muscle, only 10 * 5 % of chymase-positive mast cells were near smooth muscle (see Table 1 ).
Discussion
The localization of chymase-containing mast cells in this study using enzyme histochemical procedures confirms the earlier immunohistochemical observation that only a portion of mast cells in human bronchial tissues contain chymase (6). Although the fraction of mast cells containing enzyme histochemical evidence of chymase relative to the total number of metachromatic cells varies among subepithelial compartments, e.g., gland and smooth muscle, the absolute concentration of chymase-positive cells is subject to little variation. Therefore, the amounts of chymase available for release from activated mast cells are likely to be similar throughout the airway subepithelium. The heterogeneity in total mast cell density among subepithelial compartments and the striking variation in the proportion of mast cells represented by the chymase-positive phenotype suggest that factors generated in particular airway microenvironments may influence mast cell recruitment, proliferation, and differentiation. The sources of such factors, of course, are entirely speculative, but could include the targets of mast cell mediators themselves, e.g., glands, airway smooth muscle, vessels, and nerves.
Relative to the concentration of human skin mast cells (-3000/mm3) (7), almost all of which contain chymase (6), the concentration of chymase-positive mast cells near human bronchial glands and smooth muscle, as determined in the present study, is lower. Nevertheless, the concentrations in bronchi appear to be sufficient to result in biologically significant effects after release of chymase into the extracellular milieu. If one assumes that chymase-positive mast cells contain an average of 4.5 pg ofchymase per cell (28), then the tissue concentration of chymase in the vicinity of submucosal glands and smooth muscle, based on our data, is predicted to be 2.9 and 2.0 pg/un3 (-100 nM and 70 nM), respectively, assuming a molecular weight of 30,000 (29). These tissue concentrations of chymase exceed by an order of magnitude Tissue of the subepithelium that is neither gland nor smooth muscle.
the levels of chymase in solution that cause maximal stimulation of exocytosis in cultured airway submucosal gland serous cells (16). The actual concentrations of active chymase that can be achieved in the vicinity of submucosal gland cells and other targets in airway microenvironments cannot be readily predicted because they depend on a variety of factors that are difficult to account for in a quantitative fashion. These factors include the proximity of the mast cell to its targets, the percentage of mast cell chymase released extracellularly in response to a given stimulus, the rate of diffusion of chymase released in association with mast cell proteoglycan, and the volume of extracellular space available for chymase distribution in each airway compartment. The concentrations of exocytosed chymase reached in the gland and the smooth muscle compartments are almost certainly higher than one would predict using the measured volume of the compartments as the available volume of distribution, because most of the volume of these compartments is occupied by cells into which chymase does not diffuse. Another factor whose contribution at present is difficult to assess is the inactivation of chymase by local and circulating inhibitors. Available data suggest that chymase is inactivated only slowly by physiological inhibitors, especially relative to neutrophil proteases such as cathepsin G and elastase (30), and that chymase may gain protection from inhibition through its association with sulfated proteoglycans (31). Therefore, although it seems reasonable to hypothesize that sufficient amounts of chymase are released from bronchial mast cells to affect submucosal glands and other cellular and molecular targets, roles for chymase in airway tissues need to be validated by in vivo studies.
Our estimates of the concentration of total mast cells in human bronchial submucosa agree closely with those of Shanahan et al. (32) , who counted lead acetate-fixed metachromatic cells in lobar and segmental bronchi in smokers undergoing lung resection for carcinoma. The -23% of chymase-positive cells found by Irani et al. (6) in airway submucosa falls within the range of values (a low of 14% near smooth muscle, a high of 73% near glands) found in the present study. However, our overall figure (35%) for percentage chymase-positive cells in the bronchial subepithelium is higher than that reported by Irani et al. This discrepancy may reflect differences in the types of tissue studied (bronchioles vs bronchi) and/or differences in the sensitivity of the two chymase visualization techniques (enzyme histochemistry vs immunohistochemistry). The latter possibility is suggested by the recent report (7) of improved sensitivity of a chymase monoclonal antibody-based technique relative to the polyclonal antibody-based technique used to detect chymase in bronchial subepithelium.
